Survey of Experiences with Paxlovid(R) as a Treatment for COVID-19

Survey Demographics

Patient survey on Paxlovid(R) COVID-19 treatment. We invite all who have received Paxlovid(R) as a treatment for one or more COVID-19 infections, or those who have not received Paxlovid(R) but might receive it for a future COVID-19 infection, to complete this survey.

This survey is intended to gather patient/caregiver perspectives to inform the Save Your Skin Foundation treatment recommendations to the CADTH Common Drug Review (CDR). By providing direct patient feedback we can help inform decision-makers as to the patient need, and potentially increase treatment options and access, therefore improving treatment outcomes.

This survey should take approximately 15 minutes to complete in full.  Please contact us at info@saveyourskin.ca with any questions or additional feedback. Thank you.

Paxlovid(R) is for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults with positive results of direct sever acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death. Paxlovid (R) consists of 2 medicines: nirmatrelvir tablets and ritonavir tablets. The 2 medicines are taken together 2 times each day for 5 days.

Please note that while Save Your Skin Foundation is a non-profit dedicated to melanoma, non-melanoma skin cancers, and ocular melanoma, this survey is open to everyone who has received Paxlovid(R) or might benefit from it in the future; you do not need to have experienced one of the diseases related to Save Your Skin Foundation’s mandate to take this survey. While this survey was developed by Save Your Skin Foundation, we acknowledge and appreciate the efforts of all of those who offered feedback on this survey and are sharing it to their networks.
Section 1: Survey Demographics
1.What is your gender?
2.What is your age?
3.If you live in Canada, in what province/territory do you reside?
4.If you do not live in Canada, in what country do you reside?
5.Please indicate what you consider your “primary” health concern. You will have the opportunity to list other health concerns in the next question.
6.Please list any other major health concerns you are currently facing, other than what you previously listed as your primary health concern.
7.Below are listed the factors (according to Health Canada) that place patients at high risk of progression to severe COVID-19. Please select every factor that applies to you. Please feel free to list anything else you feel might be relevant under “other.”
Please note that other medical conditions or factors (i.e., race or ethnicity) may also place individual patients at high risk for progression to severe COVID-19 and is not limited to the medical conditions or factors listed.
Section 2: COVID-19 Related Questions
8.Have you been vaccinated against COVID-19? If possible, please indicate which brand of vaccine(s) you have received in the comment box.
9.If you have had COVID-19, how many times have you had it?
Once you have answered this question, please hit 'next' to continue the survey.